Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
BACKGROUND: Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic ...
JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.
Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.
Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...
There were no differences at 2 years between the groups for the individual endpoints of mortality, cardiovascular mortality, heart failure rehospitalization, or aortic valve reintervention. Rates of ...
The Steam Year in Review 2024 recap reveals that the future for Valve hardware is "bright," which may bode well for the Steam Deck 2. Valve previously confirmed that it's working on Steam Deck 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results